Risk of over replacement of thyroxine
Osteoporosis
HTN management in a diabetic
ACEi and ARBs are preferred at any age
(ARB if afro-caribbean origin)
How is familial hypercholesterolaemia inherited?
Autosomal dominant
Example of an SGLT2 inhibitor
Empagliflozin
Side effect of SGLT2s
Frequent UTIs
Example of GLP1
Exenatide
Liraglutide
Semaglutide (mounjaro)
Diabetes management in a patient with established CVD
Up titrate metformin then add in SGLT2 regardless of control.
If metformin not tolerated then SGLT2 monotherapy would be the best option.
Male infetility, low volume testes, sparse pubic hair, gynaecomastia, azoospermia
Kleinfelters (XXY)
Kleinfelters hormone abnormalities
Raised FSH and LH
Low testosterone
Diabetes diagnosis fasting BM
> 7
Diabetes diagnosis random BM
> 11.1
(if symptomatic one occasion/ reading, if asymptomatic then need to repeat on a separate occasion)
T1DM blood glucose targets
(waking and before meals)
5-7 on waking
4-7 before meals
Renal threshold for stopping metformin
Cr >150 or eGFR <30
Percentage reduction target in non-HDL on statin therapy
40% at 3 months
Difference between Graves and de Quervains
de Quervains is often post viral and the goitre is tender
No treatment is required often
Contraindications to pioglitazone
Bladder cancer
How often should hba1c be measured in T1DM
Every 3-6 months
Diagnostic test for Addisons
Short synacthen
Patient presenting with hypotension, hyponatraemia, hyperkalaemia, hypoglycaemia
Addisons
Pan hypopituitism following a large PPH
Sheehans syndrome
Drugs that may cause gynaecomastia
Spironolactone
ACEi
Omeprazole
CCBs
Pre-operative Hba1c target
<69
At what age does screening for diabetic retinopathy begin
Aged 12 and over
Hba1c target for pt on monotherapy
<48